SENIOR MANAGEMENT

Mr. Wong joined the Group in July 2022, and is the Chief Operating Officer of the Group. He is responsible for establishing the operational protocol, overseeing the day-to-day operations and drive the improvement of operational efficiency and services quality. Mr. Wong owns substantial experience of over 20 years in the banking and finance industry. Mr. Wong acquired a Master’s Degree of Business Administration at Harvard Business School and a Bachelor’s Degree of Business Administration (Accounting and Finance) at The University of Hong Kong.

Prior to joining the Group, Mr. Wong had been the Chief Executive Officer and Executive Director at Clarity Medical Group (SEHK: 1406.HK) and was responsible for managing the business development and operation, as well as leading the company’s IPO effort in HKEX mainboard. Prior to this, Mr. Wong was the Managing Director of BNP Paribas (Hong Kong), the Chief Financial Officer and Executive Director of Century King Resources Group Limited (SEHK: 6885.HK), the Executive Director and Chief Financial Officer of New Times Energy (SEHK: 166.HK). Mr. Wong also accumulates extensive banking and finance experiences during his employment at Royal Bank of Scotland, Merrill Lynch, and Citi.

Dr. Eric Chu is the founder of NYMG. He is responsible for group operation, the integration and consolidation for the post M&A medical projects, corporatizing medical assets, value alignment and Co-Ownership deployment.

Dr. Chu is a registered chiropractor in Hong Kong and has over 19 years of professional experience. Dr. Chu is a fellow of the Royal College of Chiropractors, is the Chairman of Chiropractic Doctors Association of Hong Kong, and is the Advisory Peer Group of the Open University of Hong Kong. Prior to joining the Group, Dr. Chu was the founder of NYMG and responsible for the overall management and strategic planning and development. Prior to establishing NYMG, Dr. Chu had previously practice in New York, the United States and Vancouver, Canada. Dr. Chu obtained a degree of Bachelor of Science from Queen’s University, Canada in 1998, and Doctor of Chiropractic from New York Chiropractic College in 2002.

Ms. Mak is experienced in marketing and medical business operation. She is responsible for developing and implementing marketing strategy, business operation and integration, and internal control.

Ms. Mak has over 15 years of professional experience in medical business management. Ms. Mak obtained a degree of Bachelor of Business Administration in Marketing from the Hong Kong University of Science and Technology in 2001. Prior to joining the Group, Ms. Mak was the managing director of NYMG and responsible for the overall operations management and business development.

Dr. Eugene Chan is appointed by the Group as Chief Public Affairs Officer responsible for the Group’s public affairs to oversee the Group’s healthcare business in line with the HKSAR Government’s policy.

Dr. Chan has more than 30 years’ experience in professional matters in Hong Kong and has served on various HKSAR Government’s advisory and statutory bodies. Dr. Chan acquired a bachelor’s degree of Dental Surgery at the University of Adelaide, attained the Memberships of Faculty of General Dental Practice (UK) [MFGDP(UK)], Membership of General Dental Dentistry of the Hong Kong College of Dental Surgeons [MGD(CDSHK)], and was conferred the Fellowship of the Faculty of General Dental Practitioners (UK) and Diploma in Implant Dentistry (Dip. Imp. Dent RCS Eng). Dr. Chan is now an Honorary Clinical Associate Professor of the Chinese University of Hong Kong, a Visiting Professor of the Jinan University in the People’s Republic of China, as well as the Chairman of The Outstanding Young Persons’ Association and President of the Association of Hong Kong Professionals. In addition, he has also served on various healthcare and professional organisations in Hong Kong and overseas.

Dr. Chan has been actively engaged in public affairs, he is a current member of Action Committee Against Narcotics, a member of Fight Crime Committee, a Council Member of City University of Hong Kong, a member of the Advisory Committee of School of Chinese Medicine of Hong Kong Baptist University, and the anchor host of weekly English current affairs programme Straight Talk. Dr. Chan was selected as an awardee of the Ten Outstanding Young Persons and appointed by the Government of the Hong Kong Special Administrative Region as a non-official Justice of the Peace and was awarded a Bronze Bauhinia Star in 2016 and Silver Bauhinia Star in 2021.

Dr. Julie Chow joined the Group in 2017 and was appointed as Chief Proposition Officer (Healthcare) in January 2023. She is responsible for scaling up the Group's strategic collaboration across government, community, insurance, corporates and other partnership. Dr. Chow has over 30 years of professional experience in strategic planning, service modeling and reengineering, business proposition, and healthcare engagement in the public and private sectors. Dr. Chow acquired a Master's Degree in Business Administration at Frankfurt School of Finance & Management and a Doctor of Business Administration degree from University of Newcastle.
Prior to joining EC Healthcare, Dr. Julie has held top management positions in healthcare and insurance companies.